Douglas Forsyth insider trades

Open-market stock purchases and sales by Douglas Forsyth, Director at Inhibrx Biosciences, Inc, from SEC Form 4 filings since Jun 25, 2014.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -13%.

Recent trades

DateStockTradeValue
Sep 8, 2026INBX Inhibrx Biosciences, IncBought$287K
Jun 3, 2026INBX Inhibrx Biosciences, IncBought (not open market)—
Jun 3, 2026INBX Inhibrx Biosciences, IncBought (not open market)—

Companies traded

  • INBX Inhibrx Biosciences, Inc: 3 buys, last Sep 8, 2026
  • INXB Inhibrx Biosciences, Inc: other filings, last May 30, 2024
  • NIE AllianzGI Equity & Convertible Income Fund: 8 sales, last Aug 11, 2020
  • NCV AllianzGI Convertible & Income Fund: 3 sales, last Jun 25, 2014

Get free alerts when Douglas Forsyth files a new trade →